Ailong Huang - Search Results

Year	Number of Results
2002	4
2003	13
2004	7
2005	10
2006	14
2007	6
2008	11
2009	11
2010	11
2011	27
2012	14
2013	26
2014	22
2015	20
2016	13
2017	18
2018	22
2019	29
2020	33
2021	34
2022	32
2023	31
2024	9

1

High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.

Zhou P, Chang WY, Gong DA, Xia J, Chen W, Huang LY, Liu R, Liu Y, Chen C, Wang K, Tang N, Huang AL. Zhou P, et al. Cell Metab. 2023 Nov 7;35(11):1961-1975.e6. doi: 10.1016/j.cmet.2023.09.009. Epub 2023 Oct 4. Cell Metab. 2023. PMID: 37797623

2

Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice.

Ye Q, Liu Y, Zhang G, Deng H, Wang X, Tuo L, Chen C, Pan X, Wu K, Fan J, Pan Q, Wang K, Huang A, Tang N. Ye Q, et al. Among authors: huang a. Nat Commun. 2023 Mar 14;14(1):1402. doi: 10.1038/s41467-023-37142-3. Nat Commun. 2023. PMID: 36918564 Free PMC article.

3

O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N⁶-methyladenosine-dependent manner.

Yang Y, Yan Y, Yin J, Tang N, Wang K, Huang L, Hu J, Feng Z, Gao Q, Huang A. Yang Y, et al. Among authors: huang a. Signal Transduct Target Ther. 2023 Feb 10;8(1):63. doi: 10.1038/s41392-023-01316-8. Signal Transduct Target Ther. 2023. PMID: 36765030 Free PMC article.

4

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression.

Gou D, Liu R, Shan X, Deng H, Chen C, Xiang J, Liu Y, Gao Q, Li Z, Huang A, Wang K, Tang N. Gou D, et al. Among authors: huang a. J Clin Invest. 2023 Jul 3;133(13):e161713. doi: 10.1172/JCI161713. J Clin Invest. 2023. PMID: 37166978 Free PMC article.

5

DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.

Zhou HZ, Li F, Cheng ST, Xu Y, Deng HJ, Gu DY, Wang J, Chen WX, Zhou YJ, Yang ML, Ren JH, Zheng L, Huang AL, Chen J. Zhou HZ, et al. Hepatology. 2022 Apr;75(4):847-865. doi: 10.1002/hep.32195. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34626132 Free PMC article.

6

Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.

Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, Gao Q, Zhang W, Tuo L, Pan X, Liang L, Xia J, Huang L, Yao K, Wang B, Hu Z, Huang A, Wang K, Tang N. Xiang J, et al. Among authors: huang a. J Clin Invest. 2021 Apr 15;131(8):e144703. doi: 10.1172/JCI144703. J Clin Invest. 2021. PMID: 33690219 Free PMC article.

7

Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.

Cheng ST, Hu JL, Ren JH, Yu HB, Zhong S, Wai Wong VK, Kwan Law BY, Chen WX, Xu HM, Zhang ZZ, Cai XF, Hu Y, Zhang WL, Long QX, Ren F, Zhou HZ, Huang AL, Chen J. Cheng ST, et al. J Hepatol. 2021 Mar;74(3):522-534. doi: 10.1016/j.jhep.2020.09.019. Epub 2020 Sep 25. J Hepatol. 2021. PMID: 32987030 Free article.

8

GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.

Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, Tang N. Wang Q, et al. Among authors: huang a. Cell Death Dis. 2021 Apr 30;12(5):426. doi: 10.1038/s41419-021-03718-4. Cell Death Dis. 2021. PMID: 33931597 Free PMC article.

9

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis.

Le X, Mu J, Peng W, Tang J, Xiang Q, Tian S, Feng Y, He S, Qiu Z, Ren G, Huang A, Lin Y, Tao Q, Xiang T. Le X, et al. Among authors: huang a. Theranostics. 2020 Jul 25;10(21):9495-9511. doi: 10.7150/thno.45631. eCollection 2020. Theranostics. 2020. PMID: 32863941 Free PMC article.

10

TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity.

Mao S, Cai X, Niu S, Wei J, Jiang N, Deng H, Wang W, Zhang J, Shen S, Ma Y, Wu X, Peng Q, Huang A, Wang D. Mao S, et al. Among authors: huang a. J Med Virol. 2023 Apr;95(4):e28719. doi: 10.1002/jmv.28719. J Med Virol. 2023. PMID: 37185839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

374 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year